FdaApplication

ANDA 209956

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA INC
application_typeANDA
approval_date2022-05-04

Products (4)

ProductActive ingredientStrengthDosage form
POMALIDOMIDEPOMALIDOMIDE2MGCAPSULE;ORAL
POMALIDOMIDEPOMALIDOMIDE1MGCAPSULE;ORAL
POMALIDOMIDEPOMALIDOMIDE4MGCAPSULE;ORAL
POMALIDOMIDEPOMALIDOMIDE3MGCAPSULE;ORAL

4 products